Position in DNLI
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$95,086
+$48,546 QoQ
Shares Held
3,697
+52.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#205
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NISA INVESTMENT ADVISORS, LLC holds $78,277,664 across 265 Biotechnology names. DNLI ranks #60 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,455 | $28,042,892 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
19,412 | $12,104,158 | |
| 3 | TECH |
BIO-TECHNE Corp
|
68,452 | $4,836,133 | |
| 4 | INCY |
Incyte Corp
|
26,479 | $3,001,659 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,139 | $2,751,113 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
48,369 | $2,275,277 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
6,111 | $2,045,901 | |
| 8 | EXEL |
Exelixis, Inc.
|
36,758 | $2,000,002 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $95,086 | 3,697 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $46,540 | 2,424 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $23,922 | 1,449 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $21,533 | 1,483 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $17,025 | 1,217 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $19,250 | 1,416 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,357,735 | 66,621 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,936,620 | 66,482 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $1,539,996 | 66,322 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,356,967 | 66,129 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $1,417,626 | 66,059 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $370,514 | 17,960 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $529,704 | 17,950 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $409,144 | 17,758 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $498,299 | 17,918 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $549,903 | 17,918 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $524,324 | 17,816 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $84,156 | 2,616 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $171,754 | 3,851 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $310,065 | 6,146 | Shares | Sole | 2021-10-18 | |
| 2021-06-30 | $485,857 | 6,194 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $359,387 | 6,294 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $489,493 | 5,844 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $92,799 | 2,590 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $18,376 | 760 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $8,054 | 460 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||